Back to top

J.P. Morgan Remains a Sell on Moderna (MRNA)

J.P. Morgan analyst Jessica Fye maintained a Sell rating on Moderna today and set a price target of $40.00. Fye covers the Healthcare sector, focus...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Moderna, Inc. (MRNA)